Two Sigma Investments, LP Arcus Biosciences, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 135,659 shares of RCUS stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
135,659
Previous 105,128 29.04%
Holding current value
$1.99 Million
Previous $1.6 Million 29.54%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$13.69 - $18.01 $417,969 - $549,863
30,531 Added 29.04%
135,659 $2.07 Million
Q2 2024

Aug 14, 2024
SELL
$14.59 - $18.48 $2.31 Million - $2.92 Million
-158,149 Reduced 60.07%
105,128 $1.6 Million
Q1 2024

May 15, 2024
BUY
$14.83 - $20.18 $2.23 Million - $3.03 Million
150,204 Added 132.84%
263,277 $4.97 Million
Q4 2023

Feb 14, 2024
BUY
$13.43 - $19.63 $951,622 - $1.39 Million
70,858 Added 167.85%
113,073 $2.16 Million
Q3 2023

Nov 14, 2023
BUY
$17.62 - $23.54 $743,828 - $993,741
42,215 New
42,215 $757,000
Q3 2022

Nov 14, 2022
BUY
$23.23 - $30.07 $1.16 Million - $1.5 Million
49,891 New
49,891 $1.31 Million
Q1 2022

May 16, 2022
SELL
$28.92 - $41.83 $4.64 Million - $6.71 Million
-160,336 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$31.38 - $48.47 $2.88 Million - $4.45 Million
91,891 Added 134.26%
160,336 $6.49 Million
Q3 2021

Nov 15, 2021
SELL
$26.93 - $37.68 $1.87 Million - $2.61 Million
-69,307 Reduced 50.31%
68,445 $2.39 Million
Q2 2021

Aug 16, 2021
BUY
$22.75 - $35.77 $2.36 Million - $3.72 Million
103,883 Added 306.72%
137,752 $3.78 Million
Q1 2021

May 17, 2021
SELL
$26.16 - $41.39 $4.46 Million - $7.05 Million
-170,364 Reduced 83.42%
33,869 $951,000
Q4 2020

Feb 16, 2021
SELL
$17.0 - $32.36 $6.59 Million - $12.5 Million
-387,713 Reduced 65.5%
204,233 $5.3 Million
Q3 2020

Nov 16, 2020
BUY
$17.14 - $25.47 $3.85 Million - $5.72 Million
224,628 Added 61.15%
591,946 $10.1 Million
Q2 2020

Aug 14, 2020
BUY
$13.97 - $36.56 $4.37 Million - $11.4 Million
313,047 Added 576.82%
367,318 $9.09 Million
Q1 2020

May 15, 2020
SELL
$8.78 - $19.28 $620,763 - $1.36 Million
-70,702 Reduced 56.57%
54,271 $753,000
Q4 2019

Feb 14, 2020
BUY
$7.33 - $10.79 $675,261 - $994,007
92,123 Added 280.44%
124,973 $1.26 Million
Q3 2019

Nov 14, 2019
SELL
$6.44 - $10.18 $71,052 - $112,315
-11,033 Reduced 25.14%
32,850 $299,000
Q2 2019

Aug 14, 2019
BUY
$7.29 - $13.38 $319,907 - $587,154
43,883 New
43,883 $349,000

Others Institutions Holding RCUS

# of Institutions
201
Shares Held
51.7M
Call Options Held
236K
Put Options Held
141K
View Full List

About Arcus Biosciences, Inc.

RCUS Quotes by TradingView
  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $1.06B
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email